New York, May 27: Remdesivir, the antiviral under clinical trials for treatment against novel coronavirus infection, is superior to the standard of care given to COVID-19 patients, according to a new study. The analysis, published in the New
from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/3c3Xfa5
from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/3c3Xfa5
ConversionConversion EmoticonEmoticon